4 research outputs found
Seroprevalence of HBV among people living with HIV in Anyigba, Kogi State, Nigeria
Background: Co-infection of HBV with HIV is associated with significant morbidity and mortality globally. In spite of increasing reports of HIV/HBV co-morbidities in Nigeria, little or no data exists on this subject in Anyigba. Therefore,we determined the prevalence of hepatitis B surface antigenemia among HIV positive patients on anti-retroviral treatment programme in Anyigba, Kogi State, North-Central Nigeria.Methods: Sera samples obtained from 200 consented HIV patients were screened for HBsAg using the commercial rapid test membrane-based qualitative immunoassay. A structured questionnaire was used to collect information on patients’ demographic variables and probable risk factors for HBV transmission.Results: Overall, 3.5% of HIV patients were seropositive to HBsAg and the difference between seroprevalence rates and patients’ age as well as gender was not statistically significant (p>0.05). There was significant difference between patients’ demographicvariables such as marital status (p=0.013) and educational level (p=0.004) and HBsAg seropositivity. Patients with a history of surgical applications (p=0.01) and who indulged in alcoholism (p=0.03) significantly had higher rates of concomitant HIV/HBV infection in the study area.Conclusion: Our findings underscore the importance of routine screening for HBV in the HIV infected populations especially in developing countries where the infection is endemic. We advocate for public enlightenment programmes on routes of virus acquisitions with a view to reduce the morbidity and mortality associated HIV/HBV co-infection.Keywords: HBV, HIV, co-infection, risk factors, Nigeria
Seroprevalence of HBV among people living with HIV in Anyigba, Kogi State, Nigeria
Background: Co-infection of HBV with HIV is associated with significant
morbidity and mortality globally. In spite of increasing reports of
HIV/HBV co-morbidities in Nigeria, little or no data exists on this
subject in Anyigba. Therefore,we determined the prevalence of hepatitis
B surface antigenemia among HIV positive patients on anti-retroviral
treatment programme in Anyigba, Kogi State, North-Central Nigeria.
Methods: Sera samples obtained from 200 consented HIV patients were
screened for HBsAg using the commercial rapid test membrane-based
qualitative immunoassay. A structured questionnaire was used to collect
information on patients\u2019 demographic variables and probable risk
factors for HBV transmission. Results: Overall, 3.5% of HIV patients
were seropositive to HBsAg and the difference between seroprevalence
rates and patients\u2019 age as well as gender was not statistically
significant (p>0.05). There was significant difference between
patients\u2019 demographic variables such as marital status (p=0.013)
and educational level (p=0.004) and HBsAg seropositivity. Patients with
a history of surgical applications (p=0.01) and who indulged in
alcoholism (p=0.03) significantly had higher rates of concomitant
HIV/HBV infection in the study area. Conclusion: Our findings
underscore the importance of routine screening for HBV in the HIV
infected populations especially in developing countries where the
infection is endemic. We advocate for public enlightenment programmes
on routes of virus acquisitions with a view to reduce the morbidity and
mortality associated HIV/HBV co-infection. DOI:
https://dx.doi.org/10.4314/ahs.v19i2.17 Cite as: Omatola CA, Idofe J,
Okolo M-LO, Adejo PO, Maina MM, Oyiguh JA. Sero-prevalence of HBV among
people living with HIV inAnyigba, Kogi State, Nigeria. Afri Health
Sci.2019;19(2): 1938-1946. https://dx.doi.org/10.4314/ahs.v19i2.1
Detection of Hepatitis B Surface Antigen among Febrile Patients in Ankpa, Kogi State, Nigeria
Background. Hepatitis B virus (HBV) infection has become a significant public health problem in developing countries, and the high rate of morbidity and mortality from acute and chronic infections is worrisome. Therefore, this study determined the prevalence of HBV and associated risk factors in Ankpa, Kogi State, Nigeria. Materials and Methods. Sera randomly collected from 200 participants in three public hospitals in Ankpa were screened for HBsAg using commercially available HBsAg rapid test kit (Swe-Care (R), China). Structured questionnaires were used to obtain sociodemographic details and history of exposure to risk factors. Results. Seventeen (8.5%) of the 200 patients were positive for HBsAg. Males had higher prevalence (10.89%) than females (6.06%). The age group with the highest rate of infection was 24–44 years. Patient’s occupation and marital status were significantly higher in relation to HBsAg seropositivity. Risks of HBV infection in Ankpa are sharing of sharp objects (OR = 11.62, 95% CI, 3.59–37.59), multiple sexual partners (OR = 3.39, 95% CI, 1.23–9.38), blood transfusion (OR = 13.74, 95% CI, 4.22–44.71), surgeries (OR = 3.02, 95% CI, 1.03–8.83), alcoholism (OR = 6.94, 95% CI, 2.32–20.75), mouth-to-mouth kissing (p=0.001), and contact with HBV patient (OR = 4.14, 95% CI, 1.01–17.06). People without prior knowledge of HBV infection were more infected. Conclusion. This study reaffirms the endemicity of HBV in a part of sub-Saharan African country. Public health practitioners should focus attention on apparently healthy patients in developing countries. We suggest inclusion of HBsAg screening for patients coming for routine hospital care
Recurrent Episodes of Some Mosquito-Borne Viral Diseases in Nigeria: A Systematic Review and Meta-Analysis
Different ecological zones favor the breeding of Aedes species. The molecular epidemiology of dengue virus (DENV), yellow fever virus (YFV), and Chikungunya virus (CHIKV) was determined from outbreaks and surveillance activities in Nigeria. Twenty-eight DENV, twenty-five YFV, and two CHIKV sequences from Nigeria were retrieved from GenBank. Genotyping was performed with a genome detective typing tool. The evolutionary comparison was performed by the Maximum Likelihood method on MEGA. Chi-square was used to compare the association between the proportions of viral infections at different times. Six DENV-1 were detected in 1964, 1965, 1978, 2007, and 2018. Nineteen DENV-2 strains were reported, four belonging to sylvatic VI, one belonging to cosmopolitan II, and twelve to Asian I genotype V. DENV-2 genotype VI was detected in 1966, and genotypes II and V in 2019. All three DENV-3 were detected in 2018, while only one DENV-4 was identified in 2019. YFV was reported in 1946 and then in the 60s, 70s, 80s, 90s, 2018, and 2019 with reports to date. CHIKV is still circulating following its identification in 1964 and 1965. Recurrent episodes of dengue, Chikungunya, and yellow fever continue unabated. Vector control initiatives and immunization should be greatly sustained